Health Data Management
You're clear! The Food and Drug Administration has given its clearance to the first continuous glucose monitoring system that can be used to make diabetes treatment decisions in adult patients without calibration using a blood sample from a traditional fingerstick test. The device can be worn for as long as 10 days following a 12-hour start-up period.
One State Street Plaza
New York, NY 10004
Follow Us For Updates
All audience and traffic data based on company reports and estimates as of Q1 2016.© 2017 SourceMedia LLC. All rights reserved. SourceMedia is an Observer Capital company. Use, duplication, or sale of this service, or data contained herein, is strictly prohibited.